首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2054862

醫藥市場：依分子類型、分類、藥物類型、生產方法、劑型、治療領域、通路、給藥途徑、最終用戶、年齡層、性別和地區分類

Pharmaceutical Market, By Molecule Type, By Type, By Drug Type, By Manufacturing Type, By Formulation, By Therapy Area, By Distribution Channel, By Route of Administration, By End User, By Age Group, By Gender, By Geography

出版日期: 2026年03月11日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，醫藥市場規模將達到1.96兆美元，2033年將達到3.43兆美元。預計從2026年到2033年，醫藥市場將以8.3%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1.96兆美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.30%	2033年市場規模預測：	3.43兆美元

全球醫藥市場是醫療保健產業中最具活力和發展最快的領域之一，涵蓋了全球範圍內的藥品研發、生產和分銷。這個價值數十億美元的產業是現代醫療保健體系的基石，為從常見疾病到罕見疾病等各種疾病提供必要的治療方案。醫藥產業的特點是持續創新、嚴格的法規結構以及對研發活動的大量資本投入。

大型製藥企業、生物技術公司和學名藥生產商在這個複雜的生態系統中運營，它們競相將安全有效的藥物推向市場，同時還要應對複雜的核准流程和專利保護。該產業的成長軌跡受到多種因素的影響，包括全球人口老化、慢性病盛行率上升、健康意識增強以及新興市場醫療服務覆蓋範圍擴大。此外，藥物研發、個人化醫療和數位健康解決方案等領域的技術進步正在改變傳統的製藥經營模式，並為市場擴張和治療方法創新創造新的機會。

市場動態

全球醫藥市場受多種關鍵因素驅動，持續保持強勁成長動能。這些因素包括世界人口快速老化，這必然需要更多醫療干預和慢性病管理；以及糖尿病、心血管疾病和癌症等文明病的日益普遍，這些疾病亟需創新治療方案。在政府措施和保險覆蓋範圍擴大的支持下，已開發市場和新興市場的醫療保健支出不斷成長，為製藥公司投資研發新藥製劑和治療方法創造了有利環境。

藥物研發過程中的技術進步，例如人工智慧、機器學習和精準醫療方法，正在縮短研發週期並提高新藥認證的成功率。然而，市場面臨著許多限制因素，包括嚴格的監管要求導致研發週期延長和成本增加；重磅藥物專利到期，導致學名藥藥競爭加劇，進而造成收入下降；以及來自醫療保險公司和政府機構的價格壓力，這些機構旨在遏制不斷飆升的醫療成本。此外，臨床試驗的高失敗率和藥物研發所需的大量資金仍然是製藥公司面臨的持續挑戰。儘管存在這些限制因素，市場仍蘊藏著巨大的機遇，例如基因療法、免疫療法和罕見病孤兒藥等新興治療領域的開發；進入醫療基礎設施尚在發展中的開發中國家的未開發市場；以及對根據患者個體基因譜和生物標記量身定做的個性化醫療解決方案日益成長的需求。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數創建了全球製藥市場主要公司的概況：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球醫藥市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過利用全球醫藥市場分析中使用的各種策略矩陣，相關人員可以更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第16章競爭格局

Pfizer Inc.
Johnson & Johnson
Novartis AG
Roche Holding AG
Merck & Co Inc（MSD）
Sanofi SA
GlaxoSmithKline plc（GSK）
Bristol-Myers Squibb Company
AstraZeneca plc
Eli Lilly and Company
AbbVie Inc.
Amgen Inc.
Takeda Pharmaceutical Company Limited
Bayer AG
Novo Nordisk A/S

第17章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第18章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI8528

Pharmaceutical Market is estimated to be valued at USD 1.96 Tn in 2026 and is expected to reach USD 3.43 Tn by 2033, growing at a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1.96 Tn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.30%	2033 Value Projection:	USD 3.43 Tn

The global pharmaceutical market represents one of the most dynamic and rapidly evolving sectors in the healthcare industry, encompassing the research, development, manufacturing, and distribution of drugs and medications worldwide. This multi-billion-dollar industry serves as the backbone of modern healthcare systems, providing essential therapeutic solutions for a vast array of medical conditions ranging from common ailments to rare diseases. The pharmaceutical landscape is characterized by continuous innovation, stringent regulatory frameworks, and significant capital investments in research and development activities.

Major pharmaceutical companies, biotechnology firms, and generic drug manufacturers operate within this complex ecosystem, competing to bring safe and effective medications to market while navigating intricate approval processes and patent protections. The industry's growth trajectory is influenced by several factors including aging global populations, increasing prevalence of chronic diseases, rising healthcare awareness, and expanding access to healthcare services in emerging markets. Additionally, technological advancements in drug discovery, personalized medicine, and digital health solutions are reshaping traditional pharmaceutical business models and creating new opportunities for market expansion and therapeutic innovation.

Market Dynamics

The global pharmaceutical market is propelled by several key drivers that continue to fuel its robust growth trajectory, with the primary catalyst being the rapidly aging global population that inherently requires more medical interventions and chronic disease management, coupled with the increasing prevalence of lifestyle-related diseases such as diabetes, cardiovascular disorders, and cancer that demand innovative therapeutic solutions. The rising healthcare expenditure across both developed and emerging economies, supported by government initiatives and insurance coverage expansion, creates a favorable environment for pharmaceutical companies to invest in research and development of new drug formulations and treatment modalities.

Technological advancements in drug discovery processes, including artificial intelligence, machine learning, and precision medicine approaches, are accelerating the development timeline and improving success rates for new drug approvals. However, the market faces significant restraints including stringent regulatory requirements that extend development timelines and increase costs, patent expirations of blockbuster drugs that lead to revenue erosion through generic competition, and pricing pressures from healthcare payers and government bodies seeking to control rising healthcare costs. Additionally, the high failure rates in clinical trials and the substantial capital requirements for drug development pose ongoing challenges for pharmaceutical companies. Despite these constraints, the market presents substantial opportunities through the exploration of emerging therapeutic areas such as gene therapy, immunotherapy, and orphan drugs for rare diseases, expansion into untapped markets in developing countries where healthcare infrastructure is improving, and the growing demand for personalized medicine solutions that cater to individual patient genetic profiles and biomarkers.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global pharmaceutical market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Pfizer Inc, Johnson & Johnson, Novartis AG, Roche Holding AG, Merck & Co Inc (MSD), Sanofi SA, GlaxoSmithKline plc (GSK), Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, AbbVie Inc, Amgen Inc, Takeda Pharmaceutical Company Limited, Bayer AG, and Novo Nordisk A/S.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global pharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical market.

Market Segmentation

Molecule Type Insights (Revenue, USD Tn, 2021 - 2033)
Biologics
Biosimilars
Type Insights (Revenue, USD Tn, 2021 - 2033)
Prescription Drugs
Over-the-Counter (OTC) Drugs
Drug Type Insights (Revenue, USD Tn, 2021 - 2033)
Branded
Generic
Manufacturing Type Insights (Revenue, USD Tn, 2021 - 2033)
Contract Manufacturing (CMO/CDMO)
In-House Manufacturing
Formulation Insights (Revenue, USD Tn, 2021 - 2033)
Solid Dosage Forms (Tablets, Capsules, Powders)
Liquid Dosage Forms (Solutions, Syrups, Suspensions)
Semi-Solid Forms (Ointments, Creams, Gels, Pastes)
Injectable Forms (Vials, Prefilled Syringes, IV Bags)
Inhalation Forms (Inhalers, Nebulizers)
Transdermal Forms (Patches, etc.)
Therapy Area Insights (Revenue, USD Tn, 2021 - 2033)
Oncology
Cardiovascular
Central Nervous System (CNS)
Respiratory
Infectious Diseases
Endocrinology (Diabetes, Hormonal)
Gastroenterology
Musculoskeletal (Arthritis, Osteoporosis)
Dermatology
Ophthalmology
Other (Rare Diseases / Orphan Drugs, etc.)
Distribution Channel Insights (Revenue, USD Tn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Route of Administration Insights (Revenue, USD Tn, 2021 - 2033)
Oral
Parenteral
Topical
Inhalation
Transdermal
Ophthalmic
Others (Nasal, etc.)
End User Insights (Revenue, USD Tn, 2021 - 2033)
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare / Individual Patients
Research and Academic Institutes
Others
Age Group Insights (Revenue, USD Tn, 2021 - 2033)
Adult
Pediatric
Geriatric
Gender Insights (Revenue, USD Tn, 2021 - 2033)
Male
Female
Regional Insights (Revenue, USD Tn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Pfizer Inc.
Johnson & Johnson
Novartis AG
Roche Holding AG
Merck & Co Inc (MSD)
Sanofi SA
GlaxoSmithKline plc (GSK)
Bristol-Myers Squibb Company
AstraZeneca plc
Eli Lilly and Company
AbbVie Inc.
Amgen Inc.
Takeda Pharmaceutical Company Limited
Bayer AG
Novo Nordisk A/S

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Pharmaceutical Market, By Molecule Type
- Global Pharmaceutical Market, By Type
- Global Pharmaceutical Market, By Drug Type
- Global Pharmaceutical Market, By Manufacturing Type
- Global Pharmaceutical Market, By Formulation
- Global Pharmaceutical Market, By Therapy Area
- Global Pharmaceutical Market, By Distribution Channel
- Global Pharmaceutical Market, By Route of Administration
- Global Pharmaceutical Market, By End User
- Global Pharmaceutical Market, By Age Group
- Global Pharmaceutical Market, By Gender
- Global Pharmaceutical Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Pharmaceutical Market, By Molecule Type, 2021 - 2033, (USD Tn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Biosimilars
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)

5. Global Pharmaceutical Market, By Type, 2021 - 2033, (USD Tn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Prescription Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Over-the-Counter (OTC) Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)

6. Global Pharmaceutical Market, By Drug Type, 2021 - 2033, (USD Tn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)

7. Global Pharmaceutical Market, By Manufacturing Type, 2021 - 2033, (USD Tn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Contract Manufacturing (CMO/CDMO)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
In-House Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)

8. Global Pharmaceutical Market, By Formulation, 2021 - 2033, (USD Tn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Solid Dosage Forms (Tablets, Capsules, Powders)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Liquid Dosage Forms (Solutions, Syrups, Suspensions)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Semi-Solid Forms (Ointments, Creams, Gels, Pastes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Injectable Forms (Vials, Prefilled Syringes, IV Bags)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Inhalation Forms (Inhalers, Nebulizers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Transdermal Forms (Patches, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)

9. Global Pharmaceutical Market, By Therapy Area, 2021 - 2033, (USD Tn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Central Nervous System (CNS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Endocrinology (Diabetes, Hormonal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Musculoskeletal (Arthritis, Osteoporosis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Other (Rare Diseases / Orphan Drugs, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)

10. Global Pharmaceutical Market, By Distribution Channel, 2021 - 2033, (USD Tn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)

11. Global Pharmaceutical Market, By Route of Administration, 2021 - 2033, (USD Tn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Ophthalmic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Others (Nasal, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)

12. Global Pharmaceutical Market, By End User, 2021 - 2033, (USD Tn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Homecare / Individual Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)

13. Global Pharmaceutical Market, By Age Group, 2021 - 2033, (USD Tn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)

14. Global Pharmaceutical Market, By Gender, 2021 - 2033, (USD Tn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Tn)

15. Global Pharmaceutical Market, By Region, 2021 - 2033, Value (USD Tn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Tn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Tn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Therapy Area, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Tn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Therapy Area, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Tn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Therapy Area, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Tn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Therapy Area, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Tn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Therapy Area, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Tn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Manufacturing Type, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Therapy Area, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Tn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Tn)
  - South Africa
  - North Africa
  - Central Africa

16. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co Inc (MSD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline plc (GSK)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies